Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2016 Apr 6

PMID 27044519

Citations 43

Authors

Michael Erbach

Guido Freckmann

Rolf Hinzmann

Bernhard Kulzer

Ralph Ziegler

Lutz Heinemann

Oliver Schnell

Affiliations

Soon will be listed here.

Abstract

In general, patients with diabetes performing self-monitoring of blood glucose (SMBG) can strongly rely on the accuracy of measurement results. However, various factors such as application errors, extreme environmental conditions, extreme hematocrit values, or medication interferences may potentially falsify blood glucose readings. Incorrect blood glucose readings may lead to treatment errors, for example, incorrect insulin dosing. Therefore, the diabetes team as well as the patients should be well informed about limitations in blood glucose testing. The aim of this publication is to review the current knowledge on limitations and interferences in blood glucose testing with the perspective of their clinical relevance.

Citing Articles

Development of Single-Walled Carbon Nanotube-Based Electrodes with Enhanced Dispersion and Electrochemical Properties for Blood Glucose Monitoring.

Kim D, Sobhan A, Oh J, Lee J, Park C, Lee J Biosensors (Basel). 2024; 14(12).

PMID: 39727895 PMC: 11674517. DOI: 10.3390/bios14120630.

Monitoring of the Analytical Performance of Four Different Blood Glucose Monitoring Systems: A Post-market Performance Follow-Up Study.

Mader J, Baumstark A, Tuting J, Sokol G, Schuebel R, Tong Y Diabetes Ther. 2024; 15(12):2525-2535.

PMID: 39466547 PMC: 11561228. DOI: 10.1007/s13300-024-01665-9.

Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations.

Lippi G, Pighi L, Mattiuzzi C Diagnostics (Basel). 2024; 14(18).

PMID: 39335715 PMC: 11431615. DOI: 10.3390/diagnostics14182037.

Self-Powered Microfluidics for Point-of-Care Solutions: From Sampling to Detection of Proteins and Nucleic Acids.

Vloemans D, Van Hileghem L, Ordutowski H, Dal Dosso F, Spasic D, Lammertyn J Methods Mol Biol. 2024; 2804:3-50.

PMID: 38753138 DOI: 10.1007/978-1-0716-3850-7_1.

Redox-Modified Nanostructured Electrochemical Surfaces for Continuous Glucose Monitoring in Complex Biological Fluids.

Janfaza S, Radha Shanmugam N, Jolly P, Kovur P, Singh U, MacKay S Nanomaterials (Basel). 2024; 14(9).

PMID: 38727390 PMC: 11085330. DOI: 10.3390/nano14090796.

References

Moore K, Vizzard N, Coleman C, McMahon J, Hayes R, Thompson C . Extreme altitude mountaineering and Type 1 diabetes; the Diabetes Federation of Ireland Kilimanjaro Expedition. Diabet Med. 2001; 18(9):749-55. DOI: 10.1046/j.0742-3071.2001.00568.x. View

Bergenstal R, Ahmann A, Bailey T, Beck R, Bissen J, Buckingham B . Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol. 2013; 7(2):562-78. PMC: 3737658. DOI: 10.1177/193229681300700234. View

Louie R, Sumner S, Belcher S, Mathew R, Tran N, Kost G . Thermal stress and point-of-care testing performance: suitability of glucose test strips and blood gas cartridges for disaster response. Disaster Med Public Health Prep. 2009; 3(1):13-7. PMC: 2717087. DOI: 10.1097/DMP.0b013e3181979a06. View

Baumstark A, Schmid C, Pleus S, Haug C, Freckmann G . Influence of partial pressure of oxygen in blood samples on measurement performance in glucose-oxidase-based systems for self-monitoring of blood glucose. J Diabetes Sci Technol. 2013; 7(6):1513-21. PMC: 3876329. DOI: 10.1177/193229681300700611. View

Budiman E, Samant N, Resch A . Clinical implications and economic impact of accuracy differences among commercially available blood glucose monitoring systems. J Diabetes Sci Technol. 2013; 7(2):365-80. PMC: 3737638. DOI: 10.1177/193229681300700213. View

Solnica B, Skupien J, Kusnierz-Cabala B, Slowinska-Solnica K, Witek P, Cempa A . The effect of hematocrit on the results of measurements using glucose meters based on different techniques. Clin Chem Lab Med. 2011; 50(2):361-5. DOI: 10.1515/CCLM.2011.770. View

Klonoff D, Blonde L, Cembrowski G, Chacra A, Charpentier G, Colagiuri S . Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2012; 5(6):1529-48. PMC: 3262725. DOI: 10.1177/193229681100500630. View

Montesinos P, Lorenzo I, Martin G, Sanz J, Perez-Sirvent M, Martinez D . Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica. 2008; 93(1):67-74. DOI: 10.3324/haematol.11575. View

. Guideline for management of postmeal glucose in diabetes. Diabetes Res Clin Pract. 2013; 103(2):256-68. DOI: 10.1016/j.diabres.2012.08.002. View

10.

Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L . ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med. 2011; 28(7):789-96. DOI: 10.1111/j.1464-5491.2011.03268.x. View

11.

Koschinsky T, Heckermann S, Heinemann L . Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors. J Diabetes Sci Technol. 2009; 2(1):58-66. PMC: 2769704. DOI: 10.1177/193229680800200109. View

12.

Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R . Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care. 2013; 36(10):2887-94. PMC: 3781531. DOI: 10.2337/dc13-0092. View

13.

Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A . The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: a European expert recommendation. J Diabetes Sci Technol. 2012; 6(3):665-73. PMC: 3440044. DOI: 10.1177/193229681200600323. View

14.

Bilen H, Kilicaslan A, Akcay G, Albayrak F . Performance of glucose dehydrogenase (GDH) based and glucose oxidase (GOX) based blood glucose meter systems at moderately high altitude. J Med Eng Technol. 2007; 31(2):152-6. DOI: 10.1080/03091900600861590. View

15.

Schnell O, Hinzmann R, Kulzer B, Freckmann G, Erbach M, Lodwig V . Assessing the analytical performance of systems for self-monitoring of blood glucose: concepts of performance evaluation and definition of metrological key terms. J Diabetes Sci Technol. 2013; 7(6):1585-94. PMC: 3876337. DOI: 10.1177/193229681300700619. View

16.

Weber C, Neeser K . Glucose information for tight glycemic control: different methods with different challenges. J Diabetes Sci Technol. 2010; 4(5):1269-75. PMC: 2956809. DOI: 10.1177/193229681000400529. View

17.

Oberg D, Ostenson C . Performance of glucose dehydrogenase-and glucose oxidase-based blood glucose meters at high altitude and low temperature. Diabetes Care. 2005; 28(5):1261. DOI: 10.2337/diacare.28.5.1261. View

18.

Tang Z, Du X, Louie R, Kost G . Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol. 2000; 113(1):75-86. DOI: 10.1309/QAW1-X5XW-BVRQ-5LKQ. View

19.

Polonsky W, Fisher L, Schikman C, Hinnen D, Parkin C, Jelsovsky Z . Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011; 34(2):262-7. PMC: 3024331. DOI: 10.2337/dc10-1732. View

20.

Schmid C, Haug C, Heinemann L, Freckmann G . System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions. Diabetes Technol Ther. 2013; 15(10):889-96. DOI: 10.1089/dia.2013.0047. View